Talcum Powder Cancer Lawsuit

The CDC Starts Tracking How Many American Women Are Exposed to Talc

The Centers for Disease Control and Prevention (CDC) has started keeping track of cancer rates in women who have used talc in the past

Monday, July 7, 2025 - The Centers for Disease Control and Prevention (CDC) has started a national epidemiological initiative to keep track of how many women with documented histories of talc exposure get cancer. This is in response to increased scientific and legal concern about the health effects of talcum powder. The goal of the new endeavor is to collect as much information as possible about how long-term usage of talc in the perineum may be associated to different types of cancer, especially those that affect the reproductive system. Public health activists consider the campaign as a critical step toward making the problem clearer, especially because thousands of women are still filing claims for ailments caused by talc. Talcum powder cancer lawyers are already using the program's early results to back up their claims in court, saying that corporations didn't do anything about decades' worth of internal and external evidence that showed the products could be harmful. Women who are suing over talcum powder cancer say they used it routinely without knowing the hazards. Many of them started using it as part of their normal hygiene routine when they were teenagers. These lawsuits are now part of a bigger story about public health, where a lot of people were exposed and the government didn't do anything about it. Health experts believe that the tracking system would eventually help them find patterns in demographics, usage, and illness types linked to talc use.

The CDC's official release says that the new surveillance program will interact with state cancer registries and research institutes to gather standard information on age, race, length of talc use, and particular cancer diagnoses. The government is also keeping an eye on lung disease and mesothelioma in those who have been exposed to talc, but its main focus will be on ovarian and endometrial cancers. The CDC said that there needs to be more reliable, large-scale epidemiological investigations to clear up the conflicting results of previous research. A lot of the research that is already out there is based on retrospective analysis or self-reported talc use, which makes it less reliable in legal and regulatory situations. The goal of this tracking endeavor is to get a better picture by collecting data on an ongoing basis with an eye toward the future. California, New Jersey, and Illinois are some of the places where there are many talc lawsuits. These states' public health departments are some of the first to take part. Researchers will also look into whether certain groups of people, such as women of color or those who don't have easy access to health care, may be at higher risk because of cultural, economic, or marketing reasons. The information gathered could have an effect on future FDA guidelines, health warning requirements, and standards for workplace safety. Lawyers said that if the government confirms that talc could be harmful to health, it will certainly help the plaintiffs' case and make manufacturers more responsible.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.